Investing Profile

Frank Kalkbrenner

InvestorVC
Director, Investment Manager at Boehringer Ingelheim Venture Fund
Photo of Frank Kalkbrenner, Investor at Boehringer Ingelheim Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$3.3M - $17.0M
$8.5M
9
CompanyStageDateRound SizeTotal Raised
Rinri Therapeutics
Series UnknownApr 2021$12M
$14M
Co-investors: Claire Brown (Oxford Science Enterprises)
T3 Pharmaceuticals
Series CJul 2020$27M
Series BSep 2019$12M
$39M
Amal Therapeutics
Series BNov 2018$33M
Series BSep 2017$10M
Series AMar 2016$3M
$46M
Co-investors: Frank Hensel (High-Tech Gründerfonds)
Hookipa Pharma
Series CDec 2017$60M
Series BDec 2016$11M
Series BNov 2013$27M
$110M
Co-investors: Graziano Seghezzi (Soffinova Partners)